Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8736349 | Autoimmunity Reviews | 2018 | 19 Pages |
Abstract
High fever flares and digestive involvement starting in early childhood seem to be hallmarks of HA20 clinical features. Response to colchicine is unpredictable and biotherapies like anti-TNFα and anti IL1 appear to be treatments of choice, like for other auto-inflammatory diseases. Prospective description of larger cohort of HA20 cases is needed to understand better when this disease must be looked for and how to treat these patients.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Florian Berteau, Bénédicte Rouviere, Aurélien Delluc, Alice Nau, Rozenn Le Berre, Guillaume Sarrabay, Isabelle Touitou, Claire de Moreuil,